Simon Ball
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Inflammatory Biomarkers in Disease Prognosis
- Colorectal Cancer Surgical Treatments
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Brain Metastases and Treatment
Papers in
- Oncology 4
- Cancer Immunotherapy and Biomarkers 3
- Colorectal Cancer Surgical Treatments 1
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Rachel E. Sanborn (3 shared papers)Silvia Novello (3 shared papers)Jerome H. Goldschmidt (3 shared papers)Diana Mendus (3 shared papers)Manuel Cobo (3 shared papers)Pascale Dubray‐Longeras (3 shared papers)Tien Ngoc HOANG (3 shared papers)Rodolfo Eduardo Bordoni (3 shared papers)
- Journals
- Journal of Thoracic Oncology (2 papers)Clinical Oncology (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United KingdomHungaryJapan
In The Last Decade
Simon Ball
4 papers receiving 470 citations
Simon Ball's Hit Papers
Peers
Comparison fields: 5 of 24
- Oncology 391
- Pulmonary and Respiratory Medicine 150
- Statistics and Probability 14
- Geriatrics and Gerontology 2
- Modeling and Simulation 2
Countries citing papers authored by Simon Ball
This map shows the geographic impact of Simon Ball's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Ball with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Ball more than expected).
Fields of papers citing papers by Simon Ball
This network shows the impact of papers produced by Simon Ball. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Ball. The network helps show where Simon Ball may publish in the future.
Co-authors
The 25 scholars most cited alongside Simon Ball, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial Hit paper breakdown → | 2020 | 357 |
| 2 | 2018 | 107 | |
| 3 | 2020 | 9 | |
| 4 | 2021 | 7 |
About Simon Ball
Simon Ball is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 4 papers that have together received 480 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Colorectal Cancer Surgical Treatments (1 paper). The work is most often cited by research in Oncology (391 citations), Pulmonary and Respiratory Medicine (150 citations), Statistics and Probability (14 citations), Geriatrics and Gerontology (2 citations) and Modeling and Simulation (2 citations). Simon Ball has collaborated with scholars based in United Kingdom, Hungary and Japan. Frequent co-authors include Rachel E. Sanborn, Silvia Novello, Jerome H. Goldschmidt, Diana Mendus, Manuel Cobo, Pascale Dubray‐Longeras, Tien Ngoc HOANG, Rodolfo Eduardo Bordoni, Makoto Nishio and Francesco Orlandi. Their work appears in journals such as Journal of Thoracic Oncology, Clinical Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.